Bioequivalence of Lamotrigine ER vs Lamictal XR in Healthy Subjects (Fed)

Phase 1, randomised, open-label trial of lamotrigine in epilepsy and bipolar disorder (BD) (2 arms), sponsored by Food and Drug Administration. Primary endpoints: Area Under the Lamotrigine Concentration vs. Time Curve From Sample Time Point 0 Hour to Sample Time Point 144 Hour, Area Under the Concentration-Time Curve From Time Zero to Infinity at 144 hours and 1 more. Started Jun 2016; status: completed.